je.st
news
Tag: diabetes
Mercks Omarigliptin, an Investigational Once-Weekly DPP-4 Inhibitor, Achieved Similar A1C Reductions to JANUVIA (sitagliptin) in Patients with Type 2 Diabetes Inadequately Controlled on Metformin Monotherapy
2015-09-16 16:16:00| Merck.com - Research & Development News
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that omarigliptin, Mercks investigational once-weekly DPP-4 inhibitor in development for adults with type 2 diabetes, achieved its primary efficacy endpoint in a Phase 3 study. Omarigliptin was found to be non-inferior to Mercks once-daily DPP-4 inhibitor, JANUVIA (sitagliptin), at reducing patients A1C* levels from baseline, with similar A1C reductions achieved in both groups. Language: English Contact: MerckMedia:Pam Eisele, 267-305-3558Michael Close, 310-617-1067Kristen Drake, 917-647-6223orInvestorsJustin Holko, 908-740-1879Teri Loxam, 908-740-1986 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: on
type
similar
controlled
Eli Lilly and partner pitch new diabetes drug
2015-08-28 04:34:45| Food - Topix.net
Eli Lilly and partner pitch new diabetes drug Synjardy is a combination of two existing diabetes medications that lower blood sugar levels. Check out this story on IndyStar.com: http://indy.st/1JotLRo A new drug to treat adult onset diabetes, developed by Eli Lilly and Co.
Tags: partner
drug
diabetes
pitch
Eli Lilly and partner pitch new diabetes drug
2015-08-28 01:37:04| Agriculture - Topix.net
Eli Lilly and partner pitch new diabetes drug Synjardy is a combination of two existing diabetes medications that lower blood sugar levels. Check out this story on IndyStar.com: http://indy.st/1JotLRo A new drug to treat adult onset diabetes, developed by Eli Lilly and Co.
Tags: partner
drug
diabetes
pitch
Novo Nordisk adding diabetes drug output in NC, Denmark
2015-08-26 21:38:06| Biotech - Topix.net
Danish drug maker Novo Nordisk said Wednesday it will open new factories in North Carolina and Denmark as pharmaceutical companies seek to keep up with demand for diabetes medications in an increasingly overweight world. Novo Nordisk plans to invest about $2 billion over the next five years in new production facilities in the Raleigh suburb of Clayton and near Copenhagen, Denmark.
Tags: drug
output
adding
denmark
Diabetes drug shows 1st protection from heart complications
2015-08-21 00:52:29| Biotech - Topix.net
For the first time, there's evidence that a diabetes medication, Jardiance, reduces risk of the complications that are the top killer of diabetics: heart attacks, strokes and other cardiovascular damage. Preventing those is a long-elusive goal for the millions of diabetes patients and their doctors, and one analyst who's also a trained physician even called Thursday's news of a possible groundbreaking advance a "holy grail."
Tags: shows
heart
protection
1st
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] next »